Albert Hwa Email & Phone Number | Albert Hwa, Ph.D. is a graduate of Cornell University, where he earned a bachelor's degree in Chemical Engineering. Dr. Hwa received his PhD in Biological Engineering at Massachusetts Institute of Technology. Dr. Hwa had extensive experience in research and development program planning and implementation while at JDRF, and has been involved in managing large research consortia, including the European Consortium for Islet Transplantation and the Islet Transplantation Program in Australia. He was the founder of the JDRF Encapsulation Consortium (now the Beta Cell Replacement Consortium). He was the Operations Director for Joslin's Center for Cell-Based Therapy for Diabetes (CCTD) and a Lecturer of Harvard Medical School. Under the mission of CCTD, Dr. Hwa managed and coordinated the Boston Autologous Islet Replacement Therapy program between Joslin, Harvard, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Semma Therapeutics. The program focused on deriving iPSC lines from diabetes patients and generating their insulin-producing cells as a personalized treatment for diabetes. He is now a program director within the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) at NIDDK. Within the Division of DEM, his grant portfolio includes studies that focus on the development and regeneration of the pancreatic endocrine compartment, as well as the application of this knowledge in stem cell differentiation and regenerative medicine. In addition, he participates in the Human Islet Research Network (HIRN), which organizes and supports collaborative research related to the loss of functional beta cell mass in type 1 diabetes. He is also part of the NIH project team for the Tissue Chip 2.0 Consortium, and serves as the project scientist for the Microphysiological Systems for Modeling Diabetes (MPS-MOD).

Albert Hwa

Albert Hwa, Ph.D. is a graduate of Cornell University, where he earned a bachelor's degree in Chemic...
Greater Boston, Greater Boston, United States

*50 free lookup(s) per month.

No credit card required.

Albert Hwa’s Email albert.hwa@joslin.harvard.edu

Albert Hwa’s Phone Numbers

Get ALBERT’s Phone Number (For Free)

Social Media

Albert Hwa’s Location Greater Boston, Greater Boston, United States

Albert Hwa’s Current Industry National Institute Of Diabetes And Digestive And Kidney Diseases

Albert Hwa’s Prior Industry Harvard Medical School | Joslin Diabetes Center | Jdrf | Juvenile Diabetes Research Foundation | International Biometric

Not the Albert Hwa you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

National Institute Of Diabetes And Digestive And Kidney Diseases

Program Director

2021-10-01 00:00:00 - Present

Harvard Medical School

Lecturer

2016-04-01 00:00:00 - 2021-10-01 00:00:00

Joslin Diabetes Center

Operations Director, Center for Cell-based Therapy for Diabetes

2016-02-01 00:00:00 - 2021-10-01 00:00:00

Jdrf

Director, Discovery Science

2014-09-01 00:00:00 - 2016-01-01 00:00:00

Juvenile Diabetes Research Foundation

Senior Program Scientist

2011-10-01 00:00:00 - 2014-09-01 00:00:00

International Biometric

Research Associate

2006-01-01 00:00:00 - 2006-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Albert Hwa

Albert Hwa is located at
Greater Boston, Greater Boston, United States

Albert Hwa is a Albert Hwa, Ph.D. is a graduate of Cornell University, where he earned a bachelor's degree in Chemical Engineering. Dr. Hwa received his PhD in Biological Engineering at Massachusetts Institute of Technology. Dr. Hwa had extensive experience in research and development program planning and implementation while at JDRF, and has been involved in managing large research consortia, including the European Consortium for Islet Transplantation and the Islet Transplantation Program in Australia. He was the founder of the JDRF Encapsulation Consortium (now the Beta Cell Replacement Consortium). He was the Operations Director for Joslin's Center for Cell-Based Therapy for Diabetes (CCTD) and a Lecturer of Harvard Medical School. Under the mission of CCTD, Dr. Hwa managed and coordinated the Boston Autologous Islet Replacement Therapy program between Joslin, Harvard, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Semma Therapeutics. The program focused on deriving iPSC lines from diabetes patients and generating their insulin-producing cells as a personalized treatment for diabetes. He is now a program director within the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) at NIDDK. Within the Division of DEM, his grant portfolio includes studies that focus on the development and regeneration of the pancreatic endocrine compartment, as well as the application of this knowledge in stem cell differentiation and regenerative medicine. In addition, he participates in the Human Islet Research Network (HIRN), which organizes and supports collaborative research related to the loss of functional beta cell mass in type 1 diabetes. He is also part of the NIH project team for the Tissue Chip 2.0 Consortium, and serves as the project scientist for the Microphysiological Systems for Modeling Diabetes (MPS-MOD).

Albert Hwa currently works in the National Institute Of Diabetes And Digestive And Kidney Diseases |

No Languages Available

Albert Hwa has prior
experience in the following industries:
Harvard Medical School | Joslin Diabetes Center | Jdrf | Juvenile Diabetes Research Foundation | International Biometric

Albert Hwa has the following professional experience:
National Institute Of Diabetes And Digestive And Kidney Diseases | Harvard Medical School | Joslin Diabetes Center | Jdrf | Juvenile Diabetes Research Foundation | International Biometric